Latest Oxcia News & Updates

See the latest news and media coverage for Oxcia. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Oxcia

Biotechnology company developing oxidative DNA damage response therapeutics

oxcia.com
Headquarters
Stockholm, Sweden
Founded year
2014
Company type
Public company
Number of employees
10
Industry
Pharmaceuticals

Last updated

Latest news about Oxcia

In short: Oxcia received FDA and EMA orphan-drug designations for OXC-201 in idiopathic pulmonary fibrosis.

Company announcements

Oxcia

Oxcia publishes its interim report for the second quarter of 2026

The company reports an operating profit of over 11 million SEK, refreshing clinical progress for OXC-101 and OXC-201, as well as plans for a capital raise of approximately 90 million SEK.

Unlock all announcements with a

Media coverage

Be the first to know. to get notified the second Oxcia hits the news.

Never miss news about Oxcia

Track Oxcia and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.